Sarepta Therapeutics is seeking to convert the accelerated approval of its therapeutic exon-skippers for Duchenne muscular dystrophy to full despite the drugs’ failure to improve motor function in a ...

The agency expects to issue decisions on Vyondys 53 and Amondys 45, which missed their primary endpoint in a confirmatory trial, by February 2027.

The U.S. will begin to test kratom for its potential to treat opioid disorder. In California, a complaint targets a business ...

In the long and often dispiriting quest to cure cancer, the 1998 approval of the drug Herceptin was a tremendously hopeful moment. This drug for breast cancer was the first to use a tumor-specific ...

Everyone, are you using AI? Lately, when I browse Note, I see people here and there making their own apps. I used to think that app development was something only experts could do. However, the people ...